Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 6/20 | 0.82 |
| ▸ | PPARD | Q03181 | 4/20 | 0.82 |
| ▸ | PPARA | Q07869 | 4/20 | 0.82 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.78 |
| ▸ | TRPM7 | Q96QT4 | 1/20 | 0.78 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.78 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.74 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.74 |
| ▸ | CRHBP | P24387 | 1/20 | 0.59 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.59 |
| ▸ | CNR2 | P34972 | 3/20 | 0.56 |
| ▸ | CNR1 | P21554 | 2/20 | 0.53 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.53 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.53 |
| ▸ | INHA | P05111 | 1/20 | 0.53 |
| ▸ | HTR2A | P28223 | 1/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.53 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10039862 | 1.00 | PPARG (0.82) | PPARGPPARDPPARASLC6A3TRPM7 | |
| SCHEMBL25560675 | 0.93 | PPARG (0.78) | PPARGPPARDPPARASLC6A3TRPM7 | |
| SCHEMBL25808457 | 0.91 | PPARG (0.67) | PPARGPPARDPPARASLC6A3TRPM7 | |
| SCHEMBL23465691 | 0.91 | PPARG (0.67) | PPARGPPARDPPARASLC6A3TRPM7 | |
| SCHEMBL2109843 | 0.91 | PPARG (1.00) | PPARGPPARDPPARASLC6A3TRPM7 | |
| SCHEMBL19460455 | 0.89 | SLC6A3 (0.74) | PPARGPPARDPPARASLC6A3TRPM7 | |
| SCHEMBL25560799 | 0.89 | PPARG (0.78) | PPARGPPARDPPARASLC6A3TRPM7 | |
| Cannabigerolic Acid SCHEMBL29489281 | 0.88 | SLC6A3 (1.00) | PPARGPPARDPPARASLC6A3TRPM7 | |
| Cannabigerolic Acid SCHEMBL9909324 | 0.88 | SLC6A3 (1.00) | PPARGPPARDPPARASLC6A3TRPM7 | |
| Cannabigerolic Acid SCHEMBL29611010 | 0.88 | SLC6A3 (1.00) | PPARGPPARDPPARASLC6A3TRPM7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 952 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4734961-A1 | NEW METHOD OF PRODUCING AN AQUEOUS MESOPARTICLE COMPOSITION COMPRISING A LIPOPHILIC COMPOUND | BIOGNTX R&D B.V. (NL) | 2026-05-06 | — | — | EP | claimed |
| EP-4727539-A1 | A PROCESS FOR CREATING A CANNABINOID PICO-EMULSION WITH ANTIBIOTIC PROPERTIES AND THE RESULTING PICO-EMULSION | Pico IP, LLC (US) | 2026-04-22 | — | — | EP | claimed |
| EP-4161580-B1 | CANNABINOID-HYALURONIC ACID BIOCONJUGATES | LONDON PHARMACEUTICALS AND RES CORPORATION (CA) | 2026-03-18 | — | — | EP | claimed |
| US-12568982-B2 | Systems for retaining potency in an infused beverage | VERTOSA INC. (US) | 2026-03-10 | — | — | US | claimed |
| US-12557843-B2 | Other than cannabinoids, flavonoids, and terpenes | LARSON RAYMOND LOUIS (US) | 2026-02-24 | — | — | US | claimed |
| US-20250360176-A1 | CHEWING GUM CONTAINING SYNERGISTIC MEDICINAL COMPOUNDS | LONDON PHARMACEUTICALS AND RES CORPORATION (CA) | 2025-11-27 | — | — | US | claimed |
| US-20250344763-A1 | Other Than Cannabinoids, Flavonoids, and Terpenes | LARSON RAYMOND LOUIS (US) | 2025-11-13 | — | — | US | claimed |
| WO-2025213224-A1 | TREATMENT OF KCNT1-RELATED DISORDERS | UNIVERSITY OF SOUTH AUSTRALIA (AU) | 2025-10-16 | — | — | WO | claimed |
| US-20250268924-A1 | PROCESS FOR CREATING A CANNABINOID PICO-EMULSION WITH ANTIBIOTIC PROPERTIES AND THE RESULTING PICO-EMULSION | TERRY MILES J (US) | 2025-08-28 | — | — | US | claimed |
| WO-2025137725-A2 | A METHOD OF CULTIVATING, PREPARING, AND USING A MATRIX-BLANK BIOMASS | PAULI CHRISTOPHER STEPHEN (US) | 2025-06-26 | — | — | WO | claimed |
| US-20220112625-A1 | Diagnosing and Treating Neurological and Autoimmune Diseases by Optimizing Metabolic Responses | POSTREL RICHARD (US) | 2022-04-14 | — | — | US | claimed |
| US-20220110911-A1 | CANNABINOID COMPOSITION AND PROCESSES OF MANUFACTURE | VIALPANDO, LLC (US) | 2022-04-14 | — | — | US | claimed |
| EP-3976769-A1 | GENETICALLY MODIFIED HOST CELLS PRODUCING GLYCOSYLATED CANNABINOIDS | Octarine Bio IVS (DK) | 2022-04-06 | — | — | EP | claimed |
| US-20220098625-A1 | RECOVERY, DECARBOXYLATION, AND PURIFICATION OF CANNABINOIDS FROM ENGINEERED CELL CULTURES | CREO INGREDIENTS, INC. | 2022-03-31 | — | — | US | claimed |
| WO-2022066936-A1 | SYSTEMS FOR RETAINING POTENCY IN AN INFUSED BEVERAGE | VERTOSA INC. (US) | 2022-03-31 | — | — | WO | claimed |
| US-20220087289-A1 | SYSTEMS FOR RETAINING POTENCY IN AN INFUSED BEVERAGE | VERTOSA INC. | 2022-03-24 | — | — | US | claimed |
| CN-114207108-A | Genetically modified host cells producing glycosylated cannabinoids | 奥克塔林生物制剂公司 | 2022-03-18 | — | — | CN | claimed |
| EP-3962457-A1 | CANNABINOID COMPOSITION AND PROCESSES OF MANUFACTURE | Vialpando, LLC (US) | 2022-03-09 | — | — | EP | claimed |
| EP-3955894-A1 | SELF-EMULSIFYING DRUG DELIVERY SYSTEMS FOR DELIVERY OF LIPOPHILIC COMPOUNDS | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd (IL) | 2022-02-23 | — | — | EP | claimed |
| CN-113966213-A | Self-emulsifying drug delivery system for delivery of lipophilic compounds | 耶路撒冷希伯来大学伊森姆研究发展有限公司 | 2022-01-21 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12568982-B2 | Systems for retaining potency in an infused beverage | TTPA, SLC6A6, PROC | PPARG 346/4885PPARD 464/4885PPARA 194/4885 |
| US-20250360176-A1 | CHEWING GUM CONTAINING SYNERGISTIC MEDICINAL COMPOUNDS | CNR2, CNR1, TAS2R60 | PPARG 418/4885PPARD 485/4885PPARA 520/4885 |
| US-12557843-B2 | Other than cannabinoids, flavonoids, and terpenes | CCT5, CNR2, CPNE4 | PPARG 58/4885PPARD 340/4885PPARA 282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.